Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
作者信息
Juhan-Vague I, Stassen J M, Alessi M C, Elias A, Aillaud M F, Serradimigni A, Collen D
机构信息
University Hospital Timone, Marseille, France.
出版信息
Semin Thromb Hemost. 1989 Oct;15(4):390-4. doi: 10.1055/s-2007-1002736.
PMID:2554499
Abstract
摘要
相似文献
1
Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
Semin Thromb Hemost. 1989 Oct;15(4):390-4. doi: 10.1055/s-2007-1002736.
2
3
4
[Combined thrombolysis by pharmacokinetically different plasminogen activators].[通过药代动力学不同的纤溶酶原激活剂进行联合溶栓]
Bioorg Khim. 1998 May;24(5):376-80.
5
Laboratory control of heparin and heparin fragment treatment: an experimental study.
Semin Thromb Hemost. 1989 Oct;15(4):373-7. doi: 10.1055/s-2007-1002733.
6
7
8
The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.组织型与单链尿激酶型纤溶酶原激活剂之间协同作用的本质。
Thromb Haemost. 1989 Nov 24;62(3):909-16.
9
[Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].[使用组织型纤溶酶原激活剂和尿激酶原进行溶栓：协同作用；突变体和杂交体]
Sangre (Barc). 1989 Aug;34(4):297-9.
10
Strategy for the development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative deep vein thromboses in general surgery.
Semin Thromb Hemost. 1989 Oct;15(4):395-400. doi: 10.1055/s-2007-1002737.
Zotero 插件